You are here: Industry Insights > MHRA

News List

COVID-19 Vaccine Trials Resume in UK americanpharmaceuticalreview
September 16, 2020
Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.
UK MHRA inspection of Strides facility at Puducherry concludes successfully expresspharma
August 20, 2020
Strides Pharma Science announced the successful completion of the inspection carried out by the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA) at its Puducherry facility between 15-18 October 2019.
MHRA announces recall of Randox COVID-19 testing kits in UK europeanpharmaceuticalreview
August 14, 2020
Randox is recalling COVID-19 testing kits in the UK as a precautionary measure as they do not meet the required safety standards, the MHRA has said.
MHRA OKs Celltrion's Phase I trial of COVID drug pharmatimes
August 04, 2020
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a green light for a Phase I trial assessing Celltrion's potential COVID-19 treatment CT-P59.
UK MHRA announces two Class 2 medicine recalls europeanpharmaceuticalreview
July 24, 2020
A batch of Nitrofurantoin and all unexpired stock of Desmopressin nasal spray are being recalled in the UK, the MHRA has announced.
UK's MHRA allows early access to lumasiran for ultra-rare disease pharmatimes
July 16, 2020
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Alnylam's lumasiran a positive scientific opinion through the Early Access to Medicines Scheme (EAMS).
UK regulator says COVID-19 prevention trial of hydroxychloroquine can resume expresspharma
July 01, 2020
The decision came after the drug was found in another UK trial to have no benefit for patients already infected with COVID-19, the pandemic disease caused by the new coronavirus.
MHRA issues consent for RedHill Bioharma's Yeliva trial pharmatimes
June 30, 2020
As of this morning – Tuesday June 30 – the current recorded case count for COVID-19 (coronavirus) in the UK has reached 311,965 with 43,575 deaths.
MHRA extends access to Santhera's DMD drug via the EAMS pharmatimes
June 24, 2020
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has renewed for a further year the Early Access to Medicines Scheme (EAMS) scientific opinion for Santhera's Duchenne muscular dystrophy (DMD) drug idebenone.
Torbay Pharmaceuticals recalls two batches of Epistatus (midazolam) europeanpharmaceuticalreview
June 19, 2020
Due to a potentially faulty and incorrectly engaged child-resistant container closure, Torbay Pharmaceuticals has announced a recall of certain Epistatus (midazolam) batches.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page